Email address
[email protected]Contact number
+45 28 93 94 70Share profile
Band 3
Provided by Martin Dræbye Gantzhorn
Martin co-heads Gorrissen Federspiel's top Life Sciences Practice Group, which provides leading advice to innovative international and national Life Sciences companies, including advisory and litigation support within regulatory, market access, transactions, capital markets/PE and product liability.
Martin has decades of experience assisting Life Sciences companies at every step of the product life cycle. He is an internationally recognized expert within Regulatory Life Science, Product Liability and IP/Trade Secrets Litigation.
Knowing the pharmaceutical and medical device companies from within, he assists on various matters relating to (Nordic) market access, regulatory data protection, market strategies, regulatory approvals, PPP/OPS, pricing, clinical trials/studies, promotional
compliance, PV, SOPs/audits and product liability.
Partner, Gorrissen Federspiel since 2024
Gorrissen Federspiel 2024 -
Bech-Bruun 2017 - 2024
Horten 2010 --2016
Board Member, Life Science Law DK
IBA Life Science & Healthcare Committee Officer, European Liaison
EPLAW (European Patent Lawyers Association)
EFLA (European Food Lawyers Association)
EPLA (European Pharmaceutical Lawyers Association)
LES (Licensing Executives Society), Past President LES Scandinavia
IBA (International Bar Association)
INTA (International Trademark Association
Provided by Chambers
Provided by Chambers
Martin's in-depth knowledge of the medical industry in the Nordics and globally is a standout quality.
Martin demonstrates an exceptional ability to quickly grasp a brief and formulate a preliminary plan of action.
He has a strong commercial mindset and knows what is relevant for pharmaceutical companies.
He responds in a timely manner, and is very pragmatic and business-oriented.
He consistently exhibits remarkable availability.
Martin's in-depth knowledge of the medical industry in the Nordics and globally is a standout quality.
Martin demonstrates an exceptional ability to quickly grasp a brief and formulate a preliminary plan of action.
He has a strong commercial mindset and knows what is relevant for pharmaceutical companies.
He responds in a timely manner, and is very pragmatic and business-oriented.
He consistently exhibits remarkable availability.
Provided by Gorrissen Federspiel
Health and Life Sciences